IR@PKUHSC  > 北京大学第二临床医学院  > 泌尿外科
学科主题临床医学
Metabolic syndrome and androgen deprivation therapy in metabolic complications of prostate cancer patients
Yuan Jia-qi; Xu Tao; Zhang Xiao-wei; Yu Lu-ping; Li Qing; Liu Shi-jun; Huang Xiao-bo; Wang Xiao-feng
关键词prostate cancer hormone therapy orchiectomy metabolic syndrome individualized medicine
刊名CHINESE MEDICAL JOURNAL
2012-10-20
DOI10.3760/cma.j.issn.0366-6999.2012.20.023
125期:20页:3725-3729
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]BODY-COMPOSITION ; CARDIOVASCULAR-DISEASE ; RECEPTOR ANTAGONISTS ; RISK-FACTORS ; POPULATION ; ORCHIECTOMY ; JAPANESE ; CHINESE ; MALES ; MEN
英文摘要

Background Incidence of prostate cancer in Chinese males grows significantly in the past decades. Androgen deprivation therapy has been generally employed in the treatment of locally advanced and metastatic prostate cancer for many years, yet only little data was known about the metabolic syndrome in patients receiving hormonal therapy. This study described the prevalence and the changing trends of hormone-related metabolic complications, and analyzed their correlation with different therapies.

Methods In 125 patients treated with castration or maximal androgen blockage for at least 12 months, metabolic indicators were analyzed.

Results Totally, 13.5% patients in castration group and 30.1% patients in maximal androgen blockage group were diagnosed metabolic syndrome 12 months after the beginning of treatments (chi(2)=4.739, P=0.029). In castration group, increased triglyceride and decreased high-density lipoprotein-cholesterol were significant at the month 12, increased fasting plasma glucose and blood pressure were significant at the month 4. In maximal androgen blockage group, increased triglyceride and decreased high-density lipoprotein-cholesterol were significant at the month 4, increased fasting plasma glucose and blood pressure were significant at the month 8. Total testosterone and free testosterone in maximal androgen blockage group were significantly lower than castration group at all visits, which were proved to show positive or negative correlations with metabolic indications. Severity of metabolic complications in maximal androgen blockage group was generally more serious than people received castration, with significantly statistical difference or not. Trends of high-density lipoprotein-cholesterol and fasting plasma glucose were significant different between two kinds of therapy (P=0.005, P=0.019, respectively).

Conclusions Prostate cancer patients receiving androgen deprivation therapy were at high risk of suffering metabolic syndrome. Severity of metabolic complications under different hormonal therapies were not completely consistent, suggested that androgen deprivation therapy may be individualized. Chin Med J 2012;125(20):3725-3729

语种英语
WOS记录号WOS:000311265100024
项目编号Z101107050210025
资助机构Beijing Pharmaceutical and Technological Project Cultivation Research Foundation
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/60384
专题北京大学第二临床医学院_泌尿外科
北京大学医学部管理机构_医学部
作者单位Peking Univ, Dept Urol, Peoples Hosp, Beijing 100044, Peoples R China
推荐引用方式
GB/T 7714
Yuan Jia-qi,Xu Tao,Zhang Xiao-wei,et al. Metabolic syndrome and androgen deprivation therapy in metabolic complications of prostate cancer patients[J]. CHINESE MEDICAL JOURNAL,2012,125(20):3725-3729.
APA Yuan Jia-qi.,Xu Tao.,Zhang Xiao-wei.,Yu Lu-ping.,Li Qing.,...&Wang Xiao-feng.(2012).Metabolic syndrome and androgen deprivation therapy in metabolic complications of prostate cancer patients.CHINESE MEDICAL JOURNAL,125(20),3725-3729.
MLA Yuan Jia-qi,et al."Metabolic syndrome and androgen deprivation therapy in metabolic complications of prostate cancer patients".CHINESE MEDICAL JOURNAL 125.20(2012):3725-3729.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yuan Jia-qi]的文章
[Xu Tao]的文章
[Zhang Xiao-wei]的文章
百度学术
百度学术中相似的文章
[Yuan Jia-qi]的文章
[Xu Tao]的文章
[Zhang Xiao-wei]的文章
必应学术
必应学术中相似的文章
[Yuan Jia-qi]的文章
[Xu Tao]的文章
[Zhang Xiao-wei]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。